Difficulty: Medium
Average Score: 94%
Practice
A 6-week-old preterm infant presented with progressive pallor and peripheral edema, his blood film revealed anemia, elevated reticulocyte count, and thrombocytosis. Of the following, the BEST management of this preterm is to
Correct answer
C
Rationale
The best management for the 6-week-old preterm infant with anemia, elevated reticulocyte count, and thrombocytosis is to give folic acid (Option C). This infant likely has hemolytic anemia due to an underlying cause such as a deficiency in folic acid. Folic acid supplementation helps in the production of red blood cells and can aid in the treatment of anemia in this case.
Option A is incorrect because anemia, elevated reticulocyte count, and thrombocytosis indicate a more serious condition that requires intervention rather than just reassurance. Option B, giving packed cell blood, is not the first-line treatment for this type of anemia. Option D, repeating the CBC in 2 weeks, delays necessary treatment for the infant's condition.
Educationally, understanding the underlying pathophysiology of anemia in infants is crucial for nurses and healthcare providers caring for pediatric patients. Recognizing the signs and symptoms of different types of anemia and knowing the appropriate interventions, such as folic acid supplementation in this case, is essential for providing safe and effective care to pediatric patients with hematologic disorders.
Option A is incorrect because anemia, elevated reticulocyte count, and thrombocytosis indicate a more serious condition that requires intervention rather than just reassurance. Option B, giving packed cell blood, is not the first-line treatment for this type of anemia. Option D, repeating the CBC in 2 weeks, delays necessary treatment for the infant's condition.
Educationally, understanding the underlying pathophysiology of anemia in infants is crucial for nurses and healthcare providers caring for pediatric patients. Recognizing the signs and symptoms of different types of anemia and knowing the appropriate interventions, such as folic acid supplementation in this case, is essential for providing safe and effective care to pediatric patients with hematologic disorders.